An Act to amend the Patent Act (drugs for international humanitarian purposes) and to make a consequential amendment to another Act

This bill was last introduced in the 40th Parliament, 3rd Session, which ended in March 2011.

This bill was previously introduced in the 40th Parliament, 2nd Session.

Sponsor

Judy Wasylycia-Leis  NDP

Introduced as a private member’s bill. (These don’t often become law.)

Status

In committee (House), as of Dec. 2, 2009
(This bill did not become law.)

Summary

This is from the published bill.

This enactment amends the Patent Act and the Food and Drugs Act to make it easier to manufacture and export pharmaceutical products to address public health problems afflicting many developing and least-developed countries, especially those resulting from HIV/AIDS, tuberculosis, malaria and other epidemics.

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.

Votes

March 9, 2011 Passed That Motion No. 3 be amended by deleting all the words after the words “The provisions of this Act that amend the Patent Act” and substituting the following: “shall cease to apply on the day that is the tenth anniversary of the day on which this Act comes into force unless, before that day, the application of those provisions is subject to a comprehensive review by the standing committee designated by the House of Commons for that purpose, that committee recommends that they be maintained and the House of Commons approves that recommendation.”.
Dec. 2, 2009 Passed That the Bill be now read a second time and referred to the Standing Committee on Industry, Science and Technology.

Patent ActPrivate Members' Business

March 9th, 2011 / 6:25 p.m.


See context

An hon. member

On division.

Patent ActPrivate Members' Business

March 9th, 2011 / 6:25 p.m.


See context

The Deputy Speaker Andrew Scheer

I declare the motion carried.

(Motion agreed to, bill read the third time and passed)